Cubist Systematic Strategies, LLC Kiniksa Pharmaceuticals, Ltd. Transaction History

Cubist Systematic Strategies, LLC

$15.8 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$17.63 - $21.74 $1.18 Million - $1.46 Million	67,081 Added 186.77%	102,997 $2.03 Million
Q4 2023 Feb 14, 2024	BUY	$14.37 - $19.07 $516,112 - $684,918	35,916 New	35,916 $629,000
Q2 2023 Aug 14, 2023	BUY	$10.44 - $16.48 $420,669 - $664,045	40,294 New	40,294 $567,000
Q4 2022 Feb 14, 2023	BUY	$11.42 - $17.05 $667,715 - $996,896	58,469 Added 112.11%	110,620 $1.66 Million
Q3 2022 Nov 14, 2022	BUY	$9.76 - $13.41 $177,983 - $244,544	18,236 Added 53.77%	52,151 $670,000
Q2 2022 Aug 15, 2022	SELL	$7.6 - $11.41 $63,961 - $96,026	-8,416 Reduced 19.88%	33,915 $329,000
Q1 2022 May 16, 2022	SELL	$9.3 - $12.37 $108,149 - $143,850	-11,629 Reduced 21.55%	42,331 $421,000
Q4 2021 Feb 14, 2022	BUY	$10.39 - $15.15 $140,826 - $205,343	13,554 Added 33.54%	53,960 $635,000
Q3 2021 Nov 15, 2021	BUY	$11.39 - $16.23 $276,925 - $394,599	24,313 Added 151.08%	40,406 $460,000
Q2 2021 Aug 16, 2021	SELL	$13.22 - $19.09 $78,473 - $113,318	-5,936 Reduced 26.95%	16,093 $224,000
Q1 2021 May 17, 2021	SELL	$16.68 - $23.97 $128,836 - $185,144	-7,724 Reduced 25.96%	22,029 $408,000
Q4 2020 Feb 16, 2021	BUY	$14.8 - $21.15 $86,920 - $124,213	5,873 Added 24.59%	29,753 $526,000
Q3 2020 Nov 16, 2020	SELL	$15.21 - $25.53 $9,673 - $16,237	-636 Reduced 2.59%	23,880 $366,000
Q2 2020 Aug 14, 2020	BUY	$15.08 - $26.0 $145,310 - $250,536	9,636 Added 64.76%	24,516 $625,000
Q1 2020 May 15, 2020	SELL	$11.0 - $19.76 $9,075 - $16,302	-825 Reduced 5.25%	14,880 $230,000
Q4 2019 Feb 14, 2020	BUY	$5.24 - $12.96 $80,502 - $199,104	15,363 Added 4492.11%	15,705 $174,000
Q3 2019 Nov 14, 2019	SELL	$8.15 - $15.88 $2,917 - $5,685	-358 Reduced 51.14%	342 $3,000
Q2 2019 Aug 14, 2019	BUY	$13.2 - $20.39 $9,240 - $14,273	700 New	700 $9,000
Q3 2018 Nov 14, 2018	SELL	$13.23 - $30.93 $87,569 - $204,725	-6,619 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$16.73 - $20.35 $110,735 - $134,696	6,619 New	6,619 $115,000

Others Institutions Holding KNSA

# of Institutions

Shares Held

1.95M

Call Options Held

Put Options Held

Pictet Asset Management Sa Geneva 73, V8

1.52M
Shares

$30.2 Million
0.03% of portfolio
Spearhead Capital Advisors, LLC Wellington, FL

203K
Shares

$4.04 Million
2.82% of portfolio
Harbor Capital Advisors, Inc.

98.1K
Shares

$1.95 Million
0.08% of portfolio
Putnam Investments LLC Boston, MA

39.5K
Shares

$786,955
0.0% of portfolio
Birchview Capital, LP Burlington, VT

30K
Shares

$597,900
0.69% of portfolio

View Full List

About Kiniksa Pharmaceuticals, Ltd.

Ticker KNSA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,470,400
Market Cap $687M
Description
Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...

More about KNSA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Account